Author

David L. Holtzman

ORCID 0000-0001-9214-5685Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Allison BaumaniD· 1 shared David Hermann· 1 shared Debra Flood· 1 shared Firat KayaiD· 1 shared Gregory T. RobertsoniD· 1 shared Jansy Passiflora SarathyiD· 1 shared Khisimusi Mdluli· 1 shared Linda ChabaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Allison BaumanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintSep 17, 2026

Comprehensive preclinical reevaluation of PaBQU and DBQU regimens identifies lesional liability in hard-to-treat forms of tuberculosis

Nicholas D. Walter, Lisa M. Massoudi, Allison Bauman…·Gregory T. Robertson

This study reevaluates PaBQU and DBQU regimens in mouse models, finding they have lesional liability in complex lesions, which may explain their failure in a human trial.

DOI 10.64898/2026.09.15.751879

mouseproteomics

𝕏 PostBluesky